Isabelle D.
- Country
- France
- Department
- Médecine interne
Research Overview
- Phase 2 Randomized Double‑Blind Study of VX-828/Deutivacaftor With and Without Tezacaftor in Adults with Cystic Fibrosis
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Inhaled ETD001 in Cystic Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Long-term Safety and Efficacy of Tezacaftor, Deutivacaftor, and Vanzacaftor Combination Therapy in Patients with Cystic Fibrosis
Data & Insights
Has run more than one trial at 87 of 141 partner sites.
Specializations
Respiratory Medicine
Specializes in the treatment of cystic fibrosis, conducting research on innovative therapeutic approaches including combination therapies and inhaled treatments. The investigator explores advanced respiratory interventions focusing on improving lung function and patient outcomes.
- Combination therapy assessment
- Inhaled medication evaluation
- Pulmonary function testing
Hematology
Focuses on treating immune thrombocytopenia (ITP), investigating various therapeutic combinations including immunoglobulin treatments and corticosteroid regimens. The investigator addresses moderate to severe bleeding manifestations in adult patients.
- Immunoglobulin therapy
- Corticosteroid treatments
- Bleeding management
Rheumatology
Concentrates on treating complex autoimmune conditions including ANCA-associated vasculitis and giant cell arteritis. The investigator studies maintenance therapies and alternative treatment approaches using various immunosuppressive medications.
- Vasculitis treatment
- Immunosuppressive therapy
- Remission maintenance strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.